Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy
Construction of novel immune-related signature for prediction of pathological complete response to neoadjuvant chemotherapy in human breast cancer
Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy
Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12/PRODIGE 2 randomized trial
Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
Prognostic impact of immunophenotypic complete response in patients with multiple myeloma achieving better than complete response
